A Study to Determine the Immune Profile of Rectal Adenocarcinoma and its Correlation with the Efficacy of Neoadjuvant Chemoradiotherapy
To determine if we can predict who will respond to chemotherapy and radiation before surgery for locally advanced rectal cancer.
No discrimination will be made based on race or gender.
Patients with a diagnosis of a rectal mass suspicious for or known to be an adenocarcinoma of the rectum.
18 - 100
Healthy Volunteers Needed
Duration of Participation
From diagnosis until surgical resection
Radiological Society of North America